Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease
Diagnostics · 22.05.2025 · 15 (11) · 1303
DOI: 10.3390/diagnostics15111303 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 22.05.2025. Verfasst von Andrew M Kaz und 1 weiteren Autor:innen. Beteiligte Einrichtung: GI Section, Hospital and Specialty Medicine, VA Puget Sound Health Care System, Seattle, WA 98108, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VA Puget Sound Health Care System.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) refers to a chronic inflammatory condition involving the GI tract that includes Crohn’s disease (CD) and ulcerative colitis (UC). These conditions are believed to arise in genetically predisposed individuals who develop an exaggerated immune response to the intestinal microbiota. A timely and accurate diagnosis of IBD is essential because diagnostic delays can result in intestinal damage that is irreversible, leading in some cases to intestinal dysfunction and the need for surgery. Diagnostic delays are common in cases when GI symptoms are mild and nonspecific. When IBD is suspected, the common diagnostic algorithm includes laboratory analyses, cross-sectional radiologic imaging, and endoscopy with biopsy and histological analysis. Other diagnostic biomarkers, including those found in the serum, stool, and urine, have also been evaluated in IBD. Newer artificial intelligence (AI)-based technologies are now being developed, and these will likely play an important future role in the diagnosis and management of IBD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- GI Section, Hospital and Specialty Medicine, VA Puget Sound Health Care System, Seattle, WA 98108, USA.
- Department of Medicine/Gastroenterology, University of Washington School of Medicine, Seattle, WA 98195, USA.
- Center for Digestive Health, Virginia Mason Franciscan Health, Seattle, WA 98101, USA.
ORCID-Profile: Andrew M Kaz
Förderung
- VA Puget Sound Health Care System
Zitieren
APA
Kaz, A. M., & Venu, N. (2025). Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease. Diagnostics, 15(11), 1303. https://doi.org/10.3390/diagnostics15111303
Vancouver
Kaz AM, Venu N. Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease. Diagnostics. 2025;15(11):1303. doi:10.3390/diagnostics15111303
BibTeX
@article{Kaz2025,
author = {Kaz, Andrew M and Venu, Nanda},
title = {Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {11},
pages = {1303},
doi = {10.3390/diagnostics15111303}
}
EUVIMED